Clinical trial

A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate Cancer

NCT00625430

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2008-03-01

PhasePHASE1

Study timeline

Study start (unknown)2008-03-01Date precision: month

Registry last updated2011-07-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

Gene Directed Enzyme Prodrug Therapy, FP253/FludarabineBIOLOGICAL

Sponsors & collaborators

Biotech Equity Partners Pty Ltdlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00625430 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.